US20130064816A1 - TNF-alpha ANTAGONISTS AND METHOTREXATE IN THE TREATMENT OF TNF-MEDIATED DISEASE - Google Patents

TNF-alpha ANTAGONISTS AND METHOTREXATE IN THE TREATMENT OF TNF-MEDIATED DISEASE Download PDF

Info

Publication number
US20130064816A1
US20130064816A1 US13/645,332 US201213645332A US2013064816A1 US 20130064816 A1 US20130064816 A1 US 20130064816A1 US 201213645332 A US201213645332 A US 201213645332A US 2013064816 A1 US2013064816 A1 US 2013064816A1
Authority
US
United States
Prior art keywords
antibody
methotrexate
tnf
ca2
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/645,332
Inventor
Marc Feldmann
Ravinder Nath Maini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mathilda and Terence Kennedy Inst of Rheumatology Trust
Original Assignee
Mathilda and Terence Kennedy Inst of Rheumatology Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US08/690,775 priority Critical patent/US6270766B1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24773909&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20130064816(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to US09/754,004 priority patent/US20020010180A1/en
Priority to US11/225,631 priority patent/US7846442B2/en
Priority to US12/583,851 priority patent/US20110123543A1/en
Application filed by Mathilda and Terence Kennedy Inst of Rheumatology Trust filed Critical Mathilda and Terence Kennedy Inst of Rheumatology Trust
Priority to US13/645,332 priority patent/US20130064816A1/en
Publication of US20130064816A1 publication Critical patent/US20130064816A1/en
Application status is Abandoned legal-status Critical

Links